News
Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...
An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...
A new American Diabetes Association consensus statement provides guidance on screening, diagnosing, and managing metabolic ...
Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published in The New England Journal of Medicine. Semaglutide ...
A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.
Share on Pinterest Semaglutide may be effective in treating a form of fatty liver disease, new research shows. Steve Christo – Corbis/Getty Images Semaglutide is a GLP-1 agonist medication that ...
International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...
May 16, 2025 — A new study reveals that a single gene plays a big role in how the liver stores energy, a process that's critical for overall health and for managing diseases like type 2 diabetes.
One study found that semaglutide helps to improve liver health in people with metabolic dysfunction-associated steatohepatitis, a serious form of fatty liver disease. The use of semaglutide ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results